Moreover, in hematological malignancies, IL-32 is remarkably increased in patients with myelodysplastic syndrome (MDS), whereas patients with chronic myelomonocytic leukemia (CMML) have markedly reduced expression of IL-32 [23]. The gene discussed is IL32; the disease is myelodysplastic syndrome.